10 studies found for:    "Autoimmune hepatitis"
Show Display Options
Download search resultsDownload the search results for:
"Autoimmune hepatitis" (10 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
Condition: Autoimmune Hepatitis
Interventions: Drug: LCP-Tacro (tacrolimus);   Drug: Azathioprine
2 Withdrawn Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis
Conditions: Primary Biliary Cirrhosis;   Autoimmune Hepatitis
Intervention: Drug: Budesonide
3 Recruiting Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune Hepatitis
Condition: Autoimmune Hepatitis
Intervention: Drug: Cyclosporine-A
4 Recruiting Effect of High-protein High-fiber Diet in Patients With Autoimmune Hepatitis
Conditions: Autoimmune Hepatitis;   Cirrhosis
Intervention: Dietary Supplement: High protein high fiber diet
5 Completed Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis
Condition: Autoimmune Hepatitis
Interventions: Drug: budesonide;   Drug: prednisone
6 Recruiting Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis
Condition: Autoimmune Hepatitis
Interventions: Other: conventional plus UC-MSC treatment;   Other: Conventional plus placebo treatment
7 Completed Mycophenolate vs Azathioprin in Autoimmune Hepatitis
Condition: Autoimmune Hepatitis
Interventions: Drug: Treatment with mycophenolat mofetil;   Drug: Treatment with azathioprin
8 Unknown  Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
Conditions: Hepatitis C;   Hepatitis B;   Autoimmune Hepatitis;   Liver Cirrhosis, Biliary;   Cholangitis, Sclerosing
Intervention:
9 Terminated Autoimmune Hepatitis Study
Condition: Hepatitis, Autoimmune
Intervention:
10 Recruiting Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: ursodeoxycholic acid (UDCA) withdrawal and reinstitution

Indicates status has not been verified in more than two years